Literature DB >> 20299684

Impaired development of atherosclerosis in Abcg1-/- Apoe-/- mice: identification of specific oxysterols that both accumulate in Abcg1-/- Apoe-/- tissues and induce apoptosis.

Elizabeth J Tarling1, Dragana D Bojanic, Rajendra K Tangirala, Xuping Wang, Anita Lovgren-Sandblom, Aldons J Lusis, Ingemar Bjorkhem, Peter A Edwards.   

Abstract

OBJECTIVE: To generate Abcg1(-/-) Apoe(-/-) mice to understand the mechanism and cell types involved in changes in atherosclerosis after loss of ABCG1. METHODS AND
RESULTS: ABCG1 is highly expressed in macrophages and endothelial cells, 2 cell types that play important roles in the development of atherosclerosis. Abcg1(-/-) Apoe(-/-) and Apoe(-/-) mice and recipient Apoe(-/-) mice that had undergone transplantation with bone marrow from Apoe(-/-) or Abcg1(-/-) Apoe(-/-) mice were fed a Western diet for 12 or 16 weeks before quantification of atherosclerotic lesions. These studies demonstrated that loss of ABCG1 from all tissues, or from only hematopoietic cells, was associated with significantly smaller lesions that contained increased numbers of TUNEL- and cleaved caspase 3-positive apoptotic Abcg1(-/-) macrophages. We also identified specific oxysterols that accumulate in the brains and macrophages of the Abcg1(-/-) Apoe(-/-) mice. These oxysterols promoted apoptosis and altered the expression of proapoptotic genes when added to macrophages in vitro.
CONCLUSIONS: Loss of ABCG1 from all tissues or from only hematopoietic cells results in smaller atherosclerotic lesions populated with increased apoptotic macrophages, by processes independent of ApoE. Specific oxysterols identified in tissues of Abcg1(-/-) Apoe(-/-) mice may be critical because they induce macrophage apoptosis and the expression of proapoptotic genes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20299684      PMCID: PMC2881948          DOI: 10.1161/ATVBAHA.110.205617

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  35 in total

Review 1.  Immunoregulatory functions of surfactant proteins.

Authors:  Jo Rae Wright
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

2.  Total body ABCG1 expression protects against early atherosclerotic lesion development in mice.

Authors:  Ruud Out; Menno Hoekstra; Illiana Meurs; Paula de Vos; Johan Kuiper; Miranda Van Eck; Theo J C Van Berkel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-01-04       Impact factor: 8.311

3.  Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1-/- bone marrow.

Authors:  Mollie Ranalletta; Nan Wang; Seongah Han; Laurent Yvan-Charvet; Carrie Welch; Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-08-17       Impact factor: 8.311

Review 4.  Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency.

Authors:  Ira Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-09-01       Impact factor: 8.311

5.  Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow.

Authors:  Angel Baldán; Liming Pei; Richard Lee; Paul Tarr; Rajendra K Tangirala; Michael M Weinstein; Joy Frank; Andrew C Li; Peter Tontonoz; Peter A Edwards
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-08-03       Impact factor: 8.311

6.  Deletion of the transmembrane transporter ABCG1 results in progressive pulmonary lipidosis.

Authors:  Angel Baldán; Paul Tarr; Charisse S Vales; Joy Frank; Thomas K Shimotake; Sam Hawgood; Peter A Edwards
Journal:  J Biol Chem       Date:  2006-08-03       Impact factor: 5.157

7.  Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice.

Authors:  Ruud Out; Menno Hoekstra; Reeni B Hildebrand; Janine K Kruit; Illiana Meurs; Zhaosha Li; Folkert Kuipers; Theo J C Van Berkel; Miranda Van Eck
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-07-20       Impact factor: 8.311

8.  ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation.

Authors:  Matthew A Kennedy; Gabriel C Barrera; Kotoka Nakamura; Angel Baldán; Paul Tarr; Michael C Fishbein; Joy Frank; Omar L Francone; Peter A Edwards
Journal:  Cell Metab       Date:  2005-02       Impact factor: 27.287

9.  A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development.

Authors:  Satoko Arai; John M Shelton; Mingyi Chen; Michelle N Bradley; Antonio Castrillo; Angie L Bookout; Puiying A Mak; Peter A Edwards; David J Mangelsdorf; Peter Tontonoz; Toru Miyazaki
Journal:  Cell Metab       Date:  2005-03       Impact factor: 27.287

10.  Cellular physiology of cholesterol efflux in vascular endothelial cells.

Authors:  Brian J O'Connell; Maxime Denis; Jacques Genest
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

View more
  28 in total

1.  Association between ABCG1 polymorphism rs1893590 and high-density lipoprotein (HDL) in an asymptomatic Brazilian population.

Authors:  V H S Zago; D Z Scherrer; E S Parra; N B Panzoldo; F Alexandre; E R Nakandakare; E C R Quintão; E C de Faria
Journal:  Mol Biol Rep       Date:  2014-11-15       Impact factor: 2.316

2.  ABCG1 regulates pulmonary surfactant metabolism in mice and men.

Authors:  Thomas Q de Aguiar Vallim; Elinor Lee; David J Merriott; Christopher N Goulbourne; Joan Cheng; Angela Cheng; Ayelet Gonen; Ryan M Allen; Elisa N D Palladino; David A Ford; Tisha Wang; Ángel Baldán; Elizabeth J Tarling
Journal:  J Lipid Res       Date:  2017-03-06       Impact factor: 5.922

3.  ABCG1 deficiency promotes endothelial apoptosis by endoplasmic reticulum stress-dependent pathway.

Authors:  Jiahong Xue; Jin Wei; Xin Dong; Canzhan Zhu; Yongqin Li; Anqi Song; Zhongwei Liu
Journal:  J Physiol Sci       Date:  2013-07-30       Impact factor: 2.781

4.  Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency.

Authors:  Mi Wang; Manikandan Subramanian; Sandra Abramowicz; Andrew J Murphy; Ayelet Gonen; Joseph Witztum; Carrie Welch; Ira Tabas; Marit Westerterp; Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-03-20       Impact factor: 8.311

Review 5.  Update on HDL receptors and cellular cholesterol transport.

Authors:  Ginny Kellner-Weibel; Margarita de la Llera-Moya
Journal:  Curr Atheroscler Rep       Date:  2011-06       Impact factor: 5.113

6.  ABCG1 is required for pulmonary B-1 B cell and natural antibody homeostasis.

Authors:  Angel Baldan; Ayelet Gonen; Christina Choung; Xuchu Que; Tyler J Marquart; Irene Hernandez; Ingemar Bjorkhem; David A Ford; Joseph L Witztum; Elizabeth J Tarling
Journal:  J Immunol       Date:  2014-10-22       Impact factor: 5.422

Review 7.  HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology.

Authors:  Robert S Rosenson; H Bryan Brewer; Philip J Barter; Johan L M Björkegren; M John Chapman; Daniel Gaudet; Daniel Seung Kim; Eric Niesor; Kerry-Anne Rye; Frank M Sacks; Jean-Claude Tardif; Robert A Hegele
Journal:  Nat Rev Cardiol       Date:  2017-08-10       Impact factor: 32.419

8.  Intracellular Localization of Endogenous Mouse ABCG1 Is Mimicked by Both ABCG1-L550 and ABCG1-P550-Brief Report.

Authors:  Elizabeth J Tarling; Peter A Edwards
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-05-26       Impact factor: 8.311

9.  Tweaking the cholesterol efflux capacity of reconstituted HDL.

Authors:  Cheng-I J Ma; Jennifer A Beckstead; Airlia Thompson; Anouar Hafiane; Rui Hao Leo Wang; Robert O Ryan; Robert S Kiss
Journal:  Biochem Cell Biol       Date:  2012-05-18       Impact factor: 3.626

Review 10.  The ABCG family of membrane-associated transporters: you don't have to be big to be mighty.

Authors:  Ian D Kerr; Ameena J Haider; Ingrid C Gelissen
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.